Effects of ethinylestradiol–cyproterone acetate vs. pioglitazone–flutamide–metformin on plasma FGF21 levels in adolescent girls with androgen excess

Saved in:
Bibliographic Details
Published in:Diabetes & metabolism 2016-06, Vol.42 (3), p.196-199
Main Authors: Díaz, M, Gallego-Escuredo, J.M, de Zegher, F, Villarroya, F, Ibáñez, L
Format: Article
Language:English
Subjects:
Adolescent
Cyproterone Acetate - therapeutic use
Drug Combinations
Endocrinology & Metabolism
Ethinyl Estradiol - therapeutic use
Female
Fibroblast Growth Factors - blood
Flutamide - administration & dosage
Hirsutism - blood
Hirsutism - drug therapy
Hirsutism - etiology
Humans
Hyperandrogenism - blood
Hyperandrogenism - complications
Hyperandrogenism - drug therapy
Hyperinsulinism - blood
Hyperinsulinism - complications
Hyperinsulinism - drug therapy
Internal Medicine
Longitudinal Studies
Metformin - administration & dosage
Thiazolidinediones - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1262-3636
1878-1780
DOI:10.1016/j.diabet.2015.10.004